8.02
price up icon1.91%   0.15
after-market Dopo l'orario di chiusura: 8.25 0.23 +2.87%
loading
Precedente Chiudi:
$7.87
Aprire:
$7.86
Volume 24 ore:
23,974
Relative Volume:
0.51
Capitalizzazione di mercato:
$84.59M
Reddito:
$2.09M
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-11.97
EPS:
-0.67
Flusso di cassa netto:
$-3.64M
1 W Prestazione:
+2.82%
1M Prestazione:
+23.38%
6M Prestazione:
+70.28%
1 anno Prestazione:
+33.89%
Intervallo 1D:
Value
$7.7742
$8.25
Intervallo di 1 settimana:
Value
$7.518
$8.41
Portata 52W:
Value
$3.7223
$11.78

Nutriband Inc Stock (NTRB) Company Profile

Name
Nome
Nutriband Inc
Name
Telefono
407 377-6695
Name
Indirizzo
121 S. ORANGE AVE., ORLANDO
Name
Dipendente
3
Name
Cinguettio
Name
Prossima data di guadagno
2025-05-02
Name
Ultimi documenti SEC
Name
NTRB's Discussions on Twitter

Confronta NTRB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NTRB
Nutriband Inc
8.02 84.59M 2.09M -5.28M -3.64M -0.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Nutriband Inc Stock (NTRB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-22 Iniziato Noble Capital Markets Outperform

Nutriband Inc Borsa (NTRB) Ultime notizie

pulisher
Jun 18, 2025

Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-Up for Aversa?? Fentanyl Abuse Deterrent Fentanyl Patch - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Nutriband and Kindeva Complete Commercial Manufacturing - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Nutriband and Kindeva Complete Commercial Manufacturing Process - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Nutriband (NTRB) Advances Aversa Fentanyl Manufacturing Process | NTRB Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Nutriband, Kindeva complete commercial manufacturing process scale-up for Aversa - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Revolutionary Abuse-Deterrent Fentanyl Patch Completes Manufacturing Scale-up: $200M Market Potential - Stock Titan

Jun 18, 2025
pulisher
Jun 13, 2025

Nutriband Inc. Reports Significant Revenue Growth and Advances in AVERSA Fentanyl Development - citybuzz -

Jun 13, 2025
pulisher
Jun 10, 2025

(NTRB) Proactive Strategies - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 10, 2025

Nutriband (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology - The Globe and Mail

Jun 10, 2025
pulisher
Jun 09, 2025

Nutriband Inc. Secures U.S. Patent for Innovative Abuse-Deterrent Transdermal Technology - citybuzz -

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband secures US patent for abuse deterrent patch technology By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband issued U.S. patent for transdermal abuse deterrent technology - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology - The Manila Times

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband secures US patent for abuse deterrent patch technology - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology | NTRB Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband (NTRB) Secures Patent for Abuse Deterrent Technology | NTRB Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Nutriband Secures Game-Changing Patent for First-Ever Abuse-Deterrent Fentanyl Patch Technology - Stock Titan

Jun 09, 2025
pulisher
Jun 06, 2025

Nutriband (NASDAQ: NTRB) Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology - Barchart.com

Jun 06, 2025
pulisher
Jun 05, 2025

Nutriband (NASDAQ: NTRB): A Relentless Mission Rooted in Purpose, Innovation, and Shareholder Value - The Globe and Mail

Jun 05, 2025
pulisher
Jun 04, 2025

Nutriband Inc. Pioneers Abuse-Deterrent Technology with AVERSA, Targets $800 Million Market Potential - citybuzz -

Jun 04, 2025
pulisher
Jun 03, 2025

Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Nutriband (NASDAQ: NTRB) to Present at Noble Capital Markets Emerging Growth Virtual Conference - The Globe and Mail

Jun 03, 2025
pulisher
Jun 03, 2025

Nutriband CEO Reveals Growth Strategy: Exclusive Virtual Presentation at Noble Capital Conference - Stock Titan

Jun 03, 2025
pulisher
Jun 03, 2025

Nutriband reports Q1 revenue up 63% y/y at $667K - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

Nutriband First Quarter 2026 Earnings: EPS Beats Expectations - Yahoo Finance

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband (NASDAQ: NTRB) Posts Record Q1 Revenue, Advances AVERSA Fentanyl Development - The Globe and Mail

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. Reports Revenue Results for the First Quarter Ended April 30, 2025 - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. Provides Update on the Development of AVERSA Fentanyl - MarketScreener

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband (NTRB) Expands Kinesiology Tape Production and Advances Drug Delivery Solutions | NTRB Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. Quarterly Report Highlights Record Revenue - GlobeNewswire

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Q1 Revenue Surges 63% as AVERSA Fentanyl Development Advances | NTRBW Stock News - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Nutriband Inc. (NTRB) reports Q1 loss, misses revenue estimates - FXStreet

Jun 02, 2025
pulisher
Jun 01, 2025

Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates - MSN

Jun 01, 2025
pulisher
May 30, 2025

NutriBand Inc. SEC 10-Q Report - TradingView

May 30, 2025
pulisher
May 29, 2025

(NTRB) Investment Analysis - news.stocktradersdaily.com

May 29, 2025
pulisher
May 27, 2025

Nutriband Addresses Opioid Pain Management Challenges with Innovative Transdermal Solution - citybuzz -

May 27, 2025
pulisher
May 27, 2025

Nutriband (NASDAQ: NTRB) CEO Highlights Transdermal Pain Solution on BioMedWire Podcast - Barchart.com

May 27, 2025
pulisher
May 27, 2025

IBN Announces Latest Episode Of The Biomedwire Podcast Featuring Gareth Sheridan, CEO Of Nutriband Inc. - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc. - GlobeNewswire

May 27, 2025
pulisher
May 23, 2025

Nutriband (NASDAQ: NTRB) Charts Path To Commercialization - Barchart.com

May 23, 2025
pulisher
May 23, 2025

Stocks in play: Brookfield Corporation - The Globe and Mail

May 23, 2025
pulisher
May 23, 2025

Nutriband Advances Opioid Pain Patch Technology with Strategic Partnership - citybuzz -

May 23, 2025
pulisher
May 20, 2025

Concern Rises over Market Valutions and Structural Vibrations - The Globe and Mail

May 20, 2025
pulisher
May 18, 2025

(NTRB) On The My Stocks Page - news.stocktradersdaily.com

May 18, 2025
pulisher
May 16, 2025

Nutriband (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances - Barchart.com

May 16, 2025
pulisher
May 15, 2025

Nutriband Expands Market Presence Through Strategic Health Industry Partnerships - citybuzz -

May 15, 2025
pulisher
May 15, 2025

Why Isn't Palantir's Stock Taking Off After Another Strong Quarter? - The Globe and Mail

May 15, 2025
pulisher
May 14, 2025

Nutriband (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch - Barchart.com

May 14, 2025
pulisher
May 09, 2025

Nutriband Develops Innovative Abuse-Deterrent Fentanyl Patch Amid Opioid Crisis Regulatory Changes - citybuzz -

May 09, 2025
pulisher
May 09, 2025

Nutriband (NASDAQ: NTRB) Innovating Abuse-Deterrent Drug Delivery in a Shifting Opioid Landscape - Barchart.com

May 09, 2025

Nutriband Inc Azioni (NTRB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):